Unlocking Potential in Drug Portfolios Through Rx to OTC Switch
Seminar - London, United Kingdom
SMi's half-day masterclass will address the challenges associated with developing drug portfolios through Rx to OTC switch alongside proven methods to overcome them as highlighted by Anna Maxwell, Director, Consumer Health of Fizz Marketing Management. The event will showcase: the specifics of Rx to OTC switch, the resurgence of switch as a growth opportunity, the navigation, the process and will present an opportunity to build a value tree for a hypothetical switch.
Why you should attend the this masterclass
• Explore the resurgence of switch as a growth opportunity
• Discuss the different types of switch alongside advantages
• Discover essential insights into switch and overcome common challenges
• Understand the value tree: risk/benefit analysis
• Identify regulatory pathways in the UK and Europe
• Build strategic relationships with key industry professionals
(Courtesy of logo of Unlocking Potential in Drug Portfolios Through Rx to OTC Switch, via conferensum.com)
For more information, visit: www.smi-online.co.uk/2013pom-to-p13.asp
Thu, Jul 18, 2013 - Thu, Jul 18, 2013
Holiday Inn Bloomsbury
Coram Street, London, United Kingdom
Contact: Jonathan Collins (jcollins@smi-online.co.uk)
Phone: +44 (0) 20 7827 6734
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
